ArticleActa neuropathologica communications2016

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.

Hideyuki Arita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.